Metraipolis › archive › dc_970eff19fcfd

Intracellular Nanopharmacology of Trastuzumab Deruxtecan Reveals Lysosome-Centered Organelle Vulnerabilities in HER2-Positive Breast Cancer Cells — Europe PMC PMID:42729999

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42729999
DOI: 10.1021/acsnanomed.6c00097
License (as archived): solo-consultazione
Archived: 2026-10-18T12:08:34.199Z
SHA-256 of the archived text: 621ef3136a9153cc4964216a0be17a25c9132bb0674b9d2fc776ae847c8e5bf1
Stable URL of this page: https://metraipolis.com/documento/dc_970eff19fcfd

How to cite

Intracellular Nanopharmacology of Trastuzumab Deruxtecan Reveals Lysosome-Centered Organelle Vulnerabilities in HER2-Positive Breast Cancer Cells — Europe PMC PMID:42729999 — Europe PMC (en), https://europepmc.org/article/MED/42729999 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_970eff19fcfd (Metraipolis archive dc_970eff19fcfd, sha256 621ef3136a9153cc4964216a0be17a25c9132bb0674b9d2fc776ae847c8e5bf1)

BibTeX

@misc{dc970eff19fcfd,
  title = {Intracellular Nanopharmacology of Trastuzumab Deruxtecan Reveals Lysosome-Centered Organelle Vulnerabilities in HER2-Positive Breast Cancer Cells — Europe PMC PMID:42729999},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42729999},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_970eff19fcfd; sha256 621ef3136a9153cc4964216a0be17a25c9132bb0674b9d2fc776ae847c8e5bf1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42729999. Agents can read the archived copy with the MCP tool read_document.